News Out!!! ScripsAmerica Announces Coverage Upd
Post# of 7769
Posted On: 04/27/2015 11:06:48 AM
News Out!!!
ScripsAmerica Announces Coverage Update From SeeThruEquity
Independent Equity Research Firm Sees Dramatic Growth Driven by Specialty Pharmacy, PIMD and Physician Dispensing Businesses
April 27, 2015 10:57 ET | Source: ScripsAmerica, Inc.
TYSONS CORNER, Va., April 27, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, has issued an update to the coverage it initiated in 2014.
In its new report, SeeThruEquity believes 2015 has the potential to be a watershed year for ScripsAmerica, with revenues growing significantly over the $30 million generated in 2014. In addition to the growth anticipated in the Company's core specialty pharmacy business, both organically as well as through acquisitions, the analyst believes the Company's PIMD and Physician Dispensing Program operations will make meaningful contributions, especially over the second half of fiscal 2015. Consequently, the analyst reiterated his $1.20 per share price target.
The update report is available via the Investor Relations portion of the ScripsAmerica website. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
ScripsAmerica Announces Coverage Update From SeeThruEquity
Independent Equity Research Firm Sees Dramatic Growth Driven by Specialty Pharmacy, PIMD and Physician Dispensing Businesses
April 27, 2015 10:57 ET | Source: ScripsAmerica, Inc.
TYSONS CORNER, Va., April 27, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, has issued an update to the coverage it initiated in 2014.
In its new report, SeeThruEquity believes 2015 has the potential to be a watershed year for ScripsAmerica, with revenues growing significantly over the $30 million generated in 2014. In addition to the growth anticipated in the Company's core specialty pharmacy business, both organically as well as through acquisitions, the analyst believes the Company's PIMD and Physician Dispensing Program operations will make meaningful contributions, especially over the second half of fiscal 2015. Consequently, the analyst reiterated his $1.20 per share price target.
The update report is available via the Investor Relations portion of the ScripsAmerica website. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
(0)
(0)